Nordson Corporation
Nordson Corporation stands as a leading global player in the cold plasma market, primarily recognized for its diverse product portfolio and its core business in precision dispensing, fluid management, and surface treatment technologies. Headquartered in the U.S., the company has cultivated a strong market position through sustained proactive R&D investments and an extensive global distribution network. In the cold plasma domain, Nordson is a crucial provider of systems for surface treatment and engineering, including cleaning, activation, and coating applications essential for high-tech manufacturing. The corporation’s strategy centers on organic growth, continually launching new products that integrate advanced cold plasma capabilities to expand its market share in industrial sectors like electronics and semiconductors. Nordson’s cold plasma solutions enable manufacturers to achieve superior material adhesion, cleanliness, and functionalization on various substrates, often used to etch materials without damaging sensitive underlying components, thereby cementing its role as an indispensable infrastructure provider for high-performance fabrication worldwide. By offering robust and reliable cold plasma equipment, Nordson maintains its commitment to advancing precision in manufacturing processes globally.
Latest Market Research Report on Cold Plasma Download PDF Brochure Now
Adtec Plasma Technology Co. Ltd.
Adtec Plasma Technology Co. Ltd., based in Japan, is a globally recognized leader in plasma technologies, holding a prominent position in the cold plasma market with a wide geographic reach across numerous industries. The company’s strategic focus on rigorous research and development allows it to continuously introduce novel cold plasma products that cater to diverse applications. A significant contribution to the medical and healthcare sector is through its subsidiary, Adtec Healthcare Limited, which develops cold plasma-based devices, such as the SteriPlas, that have been widely adopted across hospitals in the UK and Europe. These medical devices leverage cold plasma for sterilization and wound healing applications, demonstrating superior efficacy and safety. Furthermore, Adtec’s technology is a key player in surface treatment and engineering, providing advanced solutions for material processing in the electronics and textiles industries. The company actively employs both organic and inorganic growth strategies, including alliances and new product launches, to enhance its product range and geographical presence, ensuring it remains at the forefront of plasma innovation and medical device advancement.
Plasmatreat GmbH
Plasmatreat GmbH is a key German player renowned for its expertise in atmospheric and low-pressure plasma technology, making it a pivotal supplier in the cold plasma market for industrial surface treatment. The company’s flagship product line, the Openair-Plasma® Jets, utilizes atmospheric plasma to achieve precise surface activation, fine cleaning, and functional coating across a broad spectrum of materials, including plastics and metals. Plasmatreat’s solutions are vital for enhancing adhesion in bonding and coating processes, improving dye uptake in textiles, and enabling innovative surface functionalization in sectors like automotive, electronics, and packaging. A notable innovation includes the development of low-temperature Openair-Plasma nozzles, such as the PFW10LT, specifically engineered for activating thermally sensitive surfaces without causing damage. By providing comprehensive and user-friendly atmospheric plasma systems, Plasmatreat addresses the growing industrial need for faster, more integrated, and environmentally friendly surface preparation methods. The company’s global presence and continuous development of process control advancements reinforce its status as a market leader driving the integration of cold plasma into existing high-volume production lines worldwide.
Apyx Medical
Apyx Medical, formerly Bovie Medical Corporation, is a key company within the cold plasma market, particularly distinguished by its focus on medical and surgical applications. Headquartered in the United States, Apyx Medical develops and manufactures advanced energy-based surgical devices. The company’s cold plasma offerings are centered around its proprietary J-Plasma/Renuvion technology, which generates a precise stream of cold atmospheric plasma using radiofrequency energy and helium gas. This technology is a game-changer in cosmetic and soft tissue surgery, offering a unique combination of controlled heat and rapid cooling to achieve tissue contraction and soft tissue coagulation with minimal thermal damage to surrounding areas. Apyx Medical’s cold plasma systems are widely adopted in aesthetic procedures, general surgery, and other clinical settings for their precision and predictable results, helping to advance patient outcomes and procedural efficiency. Its core contribution to the cold plasma sector is transforming surgical techniques through highly controlled energy delivery, solidifying its position as a major medical device innovator in this segment.
Neoplas Med GmbH
Neoplas Med GmbH, a German company, is a prominent manufacturer and developer focused exclusively on leveraging cold atmospheric pressure plasma (CAP) technology for medical and healthcare applications. As a key player in the cold plasma medical device segment, Neoplas Med’s core mission is to commercialize and distribute innovative, science-backed CAP solutions for therapeutic use. The company’s product portfolio includes devices designed for a range of clinical needs, with a strong emphasis on wound care, dermatology, and pathogen reduction. By utilizing the proven bactericidal, fungicidal, and tissue-regenerative properties of cold plasma, their devices offer advanced, non-thermal treatment options for chronic wounds and other skin conditions. The company actively collaborates on research and development to ensure its technology meets stringent regulatory and clinical standards, and it is frequently cited alongside other leaders in the medical cold plasma space. Neoplas Med’s dedicated focus on translating plasma physics into safe, effective, and accessible clinical tools underscores its critical role in expanding the adoption of cold plasma in routine medical practice across Europe and beyond.
Europlasma NV
Europlasma NV is a key technology provider in the cold plasma market, based in Belgium, specializing in low-pressure plasma systems and nanotechnology solutions for surface treatment. The company’s primary focus is the development and commercialization of nanocoating equipment and processes that utilize low-pressure cold plasma to functionalize various surfaces. These plasma-enhanced coatings, which can be applied to textiles, electronics, and filter media, are engineered to achieve specific properties such as superhydrophobicity (water repellency), oleophobicity (oil repellency), and enhanced adhesion or wettability. Europlasma’s cold plasma technology is integral to manufacturing processes where precise, uniform, and ultra-thin coatings are required to boost product performance and durability. For instance, their processes are crucial in creating waterproof yet breathable fabrics and protecting sensitive electronics from moisture and environmental contaminants. By concentrating on low-pressure vacuum plasma, Europlasma provides a highly controlled, cost-effective, and environmentally cleaner alternative to traditional wet-chemical processes, reinforcing its specialized position within the global cold plasma industry for high-performance functional coatings.
Henniker Plasma
Henniker Plasma is a leading UK-based company specializing in the design and manufacture of advanced plasma treatment systems, serving the global cold plasma market with both atmospheric and low-pressure technologies. The company provides a comprehensive suite of plasma systems used across R&D, small-scale production, and large-volume manufacturing environments. Henniker’s cold plasma systems are primarily utilized for critical surface engineering applications, including ultra-fine cleaning, surface activation to enhance bonding and adhesion, and the deposition of thin-film plasma coatings. Their technology is indispensable for researchers and manufacturers in diverse sectors such as aerospace, medical devices, and electronics, where the precise control of surface properties is paramount for product performance and reliability. By offering a range of benchtop and industrial-scale units, Henniker enables users to harness the benefits of cold plasma—improved wettability, contamination removal, and superior coating performance—to overcome complex material science challenges. As a key company in the surface treatment segment, Henniker Plasma’s commitment to scientific support and customizable solutions drives the integration of plasma processes into next-generation industrial applications.
P2i Ltd.
P2i Ltd. is a global leader and key player in the cold plasma market, distinguished by its expertise in developing and commercializing advanced hydrophobic and oleophobic protective nanocoatings. Based in the UK, the company leverages its proprietary plasma-enhanced deposition technology to create a durable, ultra-thin, and invisible layer that provides water, oil, and sweat resistance to various products. P2i’s cold plasma solutions are widely adopted across the consumer electronics, medical device, and textile industries. For instance, their technology is used to protect hearing aids and smartphones from liquid damage and to create superhydrophobic textiles that are resistant to water and stains, offering superior performance compared to traditional water-repellent treatments. The company’s process involves placing the product in a low-pressure plasma environment where a monomer is vaporized and polymerized to bond covalently to the material’s surface. This innovative approach to surface functionalization highlights P2i’s critical role in advancing product durability and performance across high-value markets, establishing them as the go-to specialist for liquid-repellent cold plasma coatings.
US Medical Innovations LLC
US Medical Innovations LLC (USMI) is a key American company driving the adoption of cold plasma technology within the medical and healthcare market. The company is dedicated to designing, manufacturing, and commercializing advanced therapeutic and surgical devices based on cold atmospheric plasma (CAP). USMI’s core focus is on developing innovative solutions for oncology and other high-impact clinical areas, leveraging the unique properties of CAP, which can selectively target and eliminate cancer cells, accelerate wound healing, and provide highly precise surgical cutting and coagulation. A notable example of their work is the Canady Cold Plasma Scalpel, which offers a non-thermal cutting mechanism for surgical procedures. By developing sophisticated plasma generators and applicators, USMI provides clinicians with next-generation tools that aim to improve patient outcomes, particularly in complex fields like tumor ablation and deep-tissue sterilization. Their commitment to integrating cold plasma into complex medical devices solidifies their status as a critical innovator pushing the boundaries of plasma medicine and making the technology a viable, cutting-edge option in operating rooms and clinics worldwide.
Relyon Plasma GmbH
Relyon Plasma GmbH, a German company and key contributor to the cold plasma market, specializes in the development and manufacture of compact, efficient, and user-friendly atmospheric plasma systems. The company’s technology portfolio includes a variety of handheld and integrated plasma systems, such as the Piezobrush series, which are designed for high-precision surface treatment, activation, and micro-fine cleaning. Relyon Plasma’s solutions are critical enablers for improving adhesion properties in various industries, including medical device manufacturing, life sciences, and electronics. The Piezobrush PZ3-i, for example, was launched to provide the life sciences and medical industries with a new, automatable way for plasma surface treatment. The company also actively engages in strategic partnerships, such as one with Viromed Medical GmbH, to advance research on cold atmospheric pressure plasma for therapeutic medical applications, covering both device development and clinical distribution. Relyon Plasma’s commitment to miniaturization and high-performance cold plasma technology ensures the seamless integration of plasma processes into existing production and R&D workflows, making it a pivotal player for accessible and reliable atmospheric plasma solutions.
Latest Market Research Report on Cold Plasma Download PDF Brochure Now